Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T58940 | ||||
Target Name | 5-HT 3B receptor (HTR3B) | ||||
Type of Target |
Discontinued |
||||
Drug Potency against Target | Cilansetron | Drug Info | Ki = 0.5 nM | [7] | |
Drug Info | Ki = 1217 nM | [3] | |||
(R)-zacopride | Drug Info | Ki = 0.7 nM | |||
2-(1H-Imidazol-4-ylmethyl)-4-phenyl-thiazole | Drug Info | Ki = 0.99 nM | [3] | ||
2-(4-Benzyl-piperazin-1-yl)-benzothiazole | Drug Info | IC50 = 3300 nM | [4] | ||
2-(4-Methyl-piperazin-1-yl)-quinoline | Drug Info | Ki = 3 nM | [1] | ||
6-(4-Methyl-piperazin-1-yl)-phenanthridine | Drug Info | Ki = 1.9 nM | [1] | ||
BRL-24682 | Drug Info | Ki = 41.8 nM | [2] | ||
MESULERGINE | Drug Info | IC50 = 2.13 nM | [5] | ||
QUIPAZINE | Drug Info | Ki = 1.8 nM | [1] | ||
SEROTONIN | Drug Info | Ki = 120 nM | [1] | ||
Action against Disease Model | Cilansetron | Drug Info | The effects of corticotropin releasing factor (CRF) and serotonin (5-HT)3 receptor antagonists on intestinal water transport were evaluated by a CRF-induced abnormal water transport model in rat colon. Centrally administered CRF (3-30 ug/kg) markedly decreased colonic fluid loss, whereas oral administration of ramosetron (3, 30 ug/kg), alosetron (300 ug/kg), cilansetron (300ug/kg), or loperamide (3 mg/kg) significantly inhibited it. Ramosetron (1-10 ug/kg), alosetron (10-100 ug/kg), cilansetron (10-100 ug/kg), or loperamide (0.3-3 mg/kg) also showed dose-dependent inhibition of CRF-induced defecation in rats. These results suggest that 5-HT3 receptors are involved in both abnormal colonic water transport and defecation induced by CRF, and that the inhibitory effectsof 5-HT3 receptor antagonists on CRF-induced abnormal defecation partly result from their ameliorating action on colonic water transport. | [6] | |
References | |||||
REF 1 | Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy ... J Med Chem. 1999 May 6;42(9):1556-75. | ||||
REF 2 | Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotoni... J Med Chem. 2003 Feb 27;46(5):702-15. | ||||
REF 3 | Aromatic thiazole derivatives: structurally novel and selective serotonin-3 receptor antagonists. J Med Chem. 1990 Jan;33(1):13-6. | ||||
REF 4 | Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties. J Med Chem. 1994 Apr 29;37(9):1320-5. | ||||
REF 5 | Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. J Med Chem. 1997 Oct 24;40(22):3670-8. | ||||
REF 6 | Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. Eur J Pharmacol. 2008 Jun 10;587(1-3):281-4. | ||||
REF 7 | IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res. 2009 Jan;37(Database issue):D680-5. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.